Athersys
ATHX
#11270
Rank
S$1.07 M
Marketcap
S$0.01741
Share price
-33.50%
Change (1 day)
-98.92%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -S$56.26 Million

According to Athersys's latest financial reports the company's current earnings are S$0.08 Million. In 2022 the company made an earning of -S$99.35 Million, an increase over its 2021 earnings that were of -S$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$56.26 Million-43.37%
2022 -S$99.35 Million-11.54%
2021 -S$0.12 Billion11.14%
2020 -S$0.11 Billion72.2%
2019 -S$58.68 Million77.29%
2018 -S$33.1 Million-22.91%
2017 -S$42.94 Million111.89%
2016 -S$20.27 Million-8.52%
2015 -S$22.16 Million-40.81%
2014 -S$37.43 Million18.62%
2013 -S$31.55 Million
2011 -S$17.78 Million19.71%
2010 -S$14.85 Million-26.28%
2009 -S$20.15 Million-18.21%
2008 -S$24.63 Million-8.28%
2007 -S$26.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.15 B-44,927.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$8.98 B-16,785.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$14.25 B-26,564.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$10.04 B-18,748.60%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$8.67 B-16,198.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$14.61 B-27,234.72%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
S$0.22 B-512.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-S$3.93 Billion 7,191.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-S$0.81 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA